News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
713,716 Results
Type
Article (52663)
Company Profile (225)
Press Release (660815)
Multimedia
Podcasts (140)
Webinars (21)
Section
Business (191677)
Career Advice (2999)
Deals (35004)
Drug Delivery (133)
Drug Development (79207)
Employer Resources (174)
FDA (16958)
Job Trends (15442)
News (331074)
Policy (32383)
Tag
2027 BioMidwest Elite (1)
2027 Biotech Bay Standard (2)
2027 Biotech Beach Elite (1)
2027 Genetown Elite (3)
2027 Genetown Standard (1)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (3)
Academia (2921)
Academic (1)
Accelerated approval (40)
Adcomms (32)
Allergies (161)
Alliances (51627)
ALS (191)
Alzheimer's disease (1783)
Antibody-drug conjugate (ADC) (358)
Approvals (17207)
Artificial intelligence (617)
Autoimmune disease (193)
Automation (48)
Bankruptcy (324)
Best Places to Work (12355)
BIOSECURE Act (20)
Biosimilars (201)
Biotechnology (153)
Bladder cancer (172)
Brain cancer (64)
Breast cancer (681)
Cancer (5225)
Cardiovascular disease (444)
Career advice (2535)
Career pathing (42)
CAR-T (309)
CDC (57)
Celiac Disease (2)
Cell therapy (834)
Cervical cancer (40)
Clinical research (67849)
Collaboration (1937)
Company closure (4)
Compensation (1221)
Complete response letters (73)
COVID-19 (2872)
CRISPR (110)
C-suite (957)
Cystic fibrosis (156)
Data (6680)
Decentralized trials (2)
Denatured (46)
Depression (150)
Diabetes (529)
Diagnostics (7215)
Digital health (51)
Diversity (12)
Diversity, equity & inclusion (42)
Drug discovery (290)
Drug pricing (200)
Drug shortages (27)
Duchenne muscular dystrophy (247)
Earnings (76804)
Editorial (65)
Employer branding (21)
Employer resources (157)
Events (114016)
Executive appointments (1059)
FDA (20288)
Fibrodysplasia Ossificans Progressiva (7)
Friedreich's ataxia (12)
Frontotemporal dementia (26)
Funding (1613)
Gene editing (232)
Generative AI (52)
Gene therapy (680)
GLP-1 (1028)
Government (4858)
Grass and pollen (8)
Guidances (386)
Healthcare (20474)
HIV (71)
Huntington's disease (51)
IgA nephropathy (89)
Immunology and inflammation (284)
Immuno-oncology (72)
Indications (134)
Infectious disease (3178)
Inflammatory bowel disease (212)
Inflation Reduction Act (15)
Influenza (132)
Intellectual property (266)
Interviews (573)
IPO (16816)
IRA (48)
Job creations (3447)
Job search strategy (2079)
JPM (64)
Kidney cancer (20)
Labor market (79)
Layoffs (564)
Leadership (43)
Legal (7492)
Liver cancer (93)
Longevity (19)
Lung cancer (694)
Lymphoma (389)
Machine learning (48)
Management (64)
Manufacturing (873)
MASH (180)
Medical device (14867)
Medtech (14932)
Mergers & acquisitions (19366)
Metabolic disorders (1356)
mRNA (187)
Multiple sclerosis (177)
NASH (21)
Neurodegenerative disease (364)
Neuropsychiatric disorders (97)
Neuroscience (3156)
NextGen: Class of 2026 (7174)
Non-profit (5013)
Now hiring (64)
Obesity (631)
Opinion (324)
Ovarian cancer (176)
Pain (228)
Pancreatic cancer (252)
Parkinson's disease (311)
Partnered (37)
Patents (538)
Patient recruitment (553)
Peanut (64)
People (57490)
Pharmaceutical (48)
Pharmacy benefit managers (30)
Phase 1 (21290)
Phase 2 (29922)
Phase 3 (22331)
Pipeline (6108)
Policy (314)
Postmarket research (2368)
Preclinical (8974)
Press Release (70)
Prostate cancer (266)
Psychedelics (53)
Radiopharmaceuticals (314)
Rare diseases (993)
Real estate (5808)
Recruiting (74)
Regulatory (24895)
Reports (36)
Research institute (2679)
Resumes & cover letters (481)
Rett syndrome (30)
RNA editing (20)
RSV (85)
Schizophrenia (158)
Series A (275)
Series B (205)
Service/supplier (10)
Sickle cell disease (110)
Special edition (22)
Spinal muscular atrophy (166)
Sponsored (47)
Startups (3685)
State (2)
Stomach cancer (16)
Supply chain (109)
Tariffs (88)
The Weekly (92)
Vaccines (1114)
Venture capital (95)
Weight loss (406)
Women's health (95)
Worklife (22)
Date
Today (154)
Last 7 days (868)
Last 30 days (3172)
Last 365 days (31719)
2026 (5660)
2025 (31940)
2024 (36886)
2023 (42133)
2022 (53455)
2021 (58154)
2020 (56905)
2019 (50194)
2018 (38023)
2017 (33962)
2016 (32790)
2015 (38280)
2014 (28888)
2013 (23849)
2012 (25699)
2011 (26390)
2010 (24049)
Location
Africa (918)
Alabama (94)
Alaska (7)
Arizona (276)
Arkansas (15)
Asia (42178)
Australia (7493)
California (12036)
Canada (3444)
China (1199)
Colorado (509)
Connecticut (526)
Delaware (354)
Europe (97924)
Florida (1810)
Georgia (396)
Hawaii (3)
Idaho (63)
Illinois (959)
India (77)
Indiana (561)
Iowa (22)
Japan (463)
Kansas (129)
Kentucky (49)
Louisiana (33)
Maine (84)
Maryland (1495)
Massachusetts (8833)
Michigan (365)
Minnesota (675)
Mississippi (7)
Missouri (144)
Montana (36)
Nebraska (30)
Nevada (133)
New Hampshire (87)
New Jersey (3244)
New Mexico (32)
New York (3176)
North Carolina (1605)
North Dakota (10)
Northern California (5906)
Ohio (370)
Oklahoma (23)
Oregon (44)
Pennsylvania (2412)
Puerto Rico (24)
Rhode Island (49)
South America (1255)
South Carolina (70)
South Dakota (1)
Southern California (4722)
Tennessee (191)
Texas (1872)
United States (43143)
Utah (368)
Vermont (1)
Virginia (290)
Washington D.C. (80)
Washington State (986)
West Virginia (4)
Wisconsin (133)
Wyoming (2)
713,716 Results for "gyros protein technologies gyros ab merged with protein technologies".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Gyros Protein Technologies Introduces Gyrolab Generic Anti-AAV Kit to Support Gene Therapy Development
Gyros Protein Technologies AB, a pioneer in automated nanoliter-scale immunoassays and leading provider of peptide synthesizers today announced the introduction of its Gyrolab® Generic Anti-Adeno Associated Virus (AAV) Kit.
June 17, 2024
·
2 min read
Drug Development
Gyros Protein Technologies Introduces Gyrolab Generic Rodent ADA Kit Reagents to Support Preclinical Immunogenicity Assessment
Gyros Protein Technologies AB announced the introduction of Gyrolab® Generic Rodent Anti-Drug Antibody Kit Reagents for the detection of circulating immune complexes of human IgG with rodent anti-human IgG.
May 2, 2024
·
2 min read
Gyros Protein Technologies and Biotage partner to advance peptide purification efficiency with new automated solution
Gyros Protein Technologies AB and Biotage announced a partnership to offer Biotage® PeptiPEC, based on Gyros’ PurePep® EasyClean catch and release technology, on Biotage® Extrahera™ automated sample preparation system.
December 7, 2023
·
2 min read
PARTNERED WITH VIVA BIOTECH
Building the Next Generation of Biologics: Inside the Future of Protein Engineering
As bispecifics, ADCs, protein degraders, and AI-designed mini-proteins move into the clinic, discovery teams face a new bottleneck: engineering and producing molecules whose complexity challenges conventional workflows.
December 1, 2025
·
9 min read
·
BioSpace Insights
Press Releases
Gyros Protein Technologies Introduces Gyrolab HEK293 HCP Type SN and Type CL Kit Reagents to Support Biotherapeutic Development
February 5, 2025
·
2 min read
Gyros Protein Technologies Introduces PurePep EasyClean Auto Kit for Automated Parallel Peptide Purification
Gyros Protein Technologies AB announced the launch of its PurePep® EasyClean Auto Kit for the automated parallel purification of peptides, accelerating downstream processes for research, development, and production of simple to complex peptide drugs and therapies.
July 27, 2023
·
2 min read
Press Releases
Nomic Publishes Foundational Protein Quantification Technology in Nature Methods
November 10, 2025
·
3 min read
Press Releases
Cancer Stress Protein Helps Tumors Hide From Immunity
February 18, 2026
·
5 min read
Press Releases
Gyre Therapeutics Enters into Agreement to Acquire Cullgen to Gain Targeted Protein Degradation Platform and Pipeline
March 2, 2026
·
10 min read
Press Releases
Origami Therapeutics Announces Global Collaboration with Ipsen to Advance Protein Degrader Program
February 2, 2026
·
2 min read
1 of 71,372
Next
